Centers for Disease Control Should Charge Fees for Various Diagnostic Laboratory Services
HRD-82-70
Published: Aug 11, 1982. Publicly Released: Aug 11, 1982.
Skip to Highlights
Highlights
GAO reviewed the extent to which the Centers for Disease Control (CDC) should be recovering the costs of diagnostic laboratory services provided to non-federal organizations and federal agencies. The review focused on certain CDC laboratory services that GAO believed had provided special benefits to the clinical laboratory industry and on similar services provided to other federal agencies.
Recommendations
Recommendations for Executive Action
| Agency Affected | Recommendation | Status |
|---|---|---|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to charge laboratory product manufacturers for field testing laboratory diagnostic products. |
Closed – Not Implemented
HHS did not concur with this recommendation but its 1985 budget submission estimated $2 million receipts from user fees. The House Appropriations Committee opposed this and deleted the user fee provision.
|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to adjust charges for laboratory training to reflect all current costs and later review and adjust such costs annually. |
Closed – Implemented
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to charge clinical laboratories, other than interstate laboratories, and federal agencies for proficiency testing. |
Closed – Not Implemented
HHS did not concur with this recommendation but its 1985 budget submission estimated $2 million receipts from user fees. The House Appropriations Committee opposed this and deleted the user fee provision.
|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to charge laboratory product manufacturers for evaluating lot samples of commercially available diagnostic reagents. |
Closed – Not Implemented
HHS did not concur with this recommendation but its 1985 budget submission estimated $2 million receipts from user fees. The House Appropriations Committee opposed this and deleted the user fee provision.
|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to charge federal agencies for laboratory training. |
Closed – Implemented
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to determine the extent to which other non-federal recipients of CDC laboratory services should be charged by applying the specific provisions of the User Charge Statute and OMB Circular A-25. |
Closed – Not Implemented
HHS did not concur with this recommendation but its 1985 budget submission estimated $2 million receipts from user fees. The House Appropriations Committee opposed this and deleted the user fee provision.
|
| Department of Health and Human Services | The Secretary of HHS should require the Director of CDC to charge laboratory product manufacturers for providing reference reagents. |
Closed – Not Implemented
HHS did not concur with this recommendation but its 1985 budget submission estimated $2 million receipts from user fees. The House Appropriations Committee opposed this and deleted the user fees provision.
|
| Department of Health and Human Services | The Secretary of HHS should propose legislation to permit the recovery of total costs for licensing services, including proficiency testing, provided under the Clinical Laboratories Improvement Act. |
Closed – Not Implemented
HHS did not concur with this recommendation but its 1985 budget submission estimated $2 million receipts from user fees. The House Appropriations Committee opposed this and deleted the user fee provision.
|
Full Report
Office of Public Affairs
Topics
LaboratoriesMedical feesReimbursements to governmentTestingUser feesFederal agenciesClinical laboratoriesField testingPublic healthDisease control